Skip to main content

Advertisement

Log in

Ivermectin—a drug and a tool

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS (2017) European guideline for the management of scabies. Eur Acad Derma Venerol. https://doi.org/10.1111/jdv.14351

  2. Fox LAM (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 19:588–593

    Article  Google Scholar 

  3. Weigl JAI (2018) Outbreaks of scabies in schools and use of Ivermectin (German). Das Gesundheitswesen 80:360–364

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josef A. I. Weigl.

Ethics declarations

Conflict of interest

The author declares that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weigl, J.A.I. Ivermectin—a drug and a tool. Eur J Clin Microbiol Infect Dis 39, 599–600 (2020). https://doi.org/10.1007/s10096-019-03806-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-019-03806-6

Navigation